Cited by 131Immunodeficiency and Autoimmune DisordersMast cells and histamineFood Allergy and Anaphylaxis Research

Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation

Open access
Siegel, Andrea M., Stone, Kelly D., Cruse, Glenn, Lawrence, Monica G., Olivera, Ana, Jung, Mi-yeon, Barber, John S., Freeman, Alexandra F. +10 more·2013·Journal of Allergy and Clinical Immunology

Abstract

Background Severe atopic conditions associated with elevated serum IgE are heterogeneous with few known causes. Nearly every patient with autosomal-dominant hyper-IgE syndrome (AD-HIES) due to signal transducer and activator of transcription 3 (STAT3) mutations has a history of eczematous dermatitis and elevated IgE; however, clinical atopy has never been systematically studied. Objective Understanding of genetic determinants of allergic disease may lead to novel therapies in controlling allergic disease. Methods We conducted clinical evaluation of the rates of food allergies and anaphylaxis in patients with AD-HIES, a cohort of patients with no STAT3 mutation but with similar histories of elevated IgE and atopic dermatitis, and healthy volunteers with no history of atopy. Morphine skin prick testing, ImmunoCAP assays for allergen-specific IgE, and basophil activation were measured. A model of systemic anaphylaxis was studied in transgenic mice carrying an AD-HIES mutation. STAT3 was silenced in LAD2 and primary human mast cells to study the role of STAT3 in signaling and degranulation after IgE cross-linking. Results Food allergies and anaphylaxis were markedly diminished in patients with AD-HIES compared with a cohort of patients with no STAT3 mutation but with similar histories of elevated IgE and atopic dermatitis. Morphine skin prick testing and basophil activation were diminished in patients with AD-HIES, whereas mice carrying an AD-HIES mutation were hyporesponsive to systemic anaphylaxis models. Rapid mast cell STAT3 serine727 phosphorylation was noted after IgE cross-linking, and inhibition of STAT3 signaling in mast cells lead to impaired FcεRI-mediated proximal and distal signaling, as well as reduced degranulation. Conclusion This study serves as an example for how mutations in specific atopic pathways can lead to discrete allergic phenotypes, encompassing increased risk of some phenotypes but a relative protection from others.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jaci.2013.08.045

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 32

  1. [1]Holland SM DeLeo FR Elloumi HZ Hsu AP Uzel G Brodsky N STAT3 mutations in the hyper-IgE syndrome N Engl J Med 2007 357 1608 1619 17881745
  2. [2]Minegishi Y Saito M Tsuchiya S Tsuge I Takada H Hara T Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome Nature 2007 448 1058 1062 17676033
  3. [3]Sowerwine KJ Holland SM Freeman AF Hyper-IgE syndrome update Ann N Y Acad Sci 2012 1250 25 32 22268731 PMC4103910
  4. [4]Buckley RH Wray BB Belmaker EZ Extreme hyperimmunoglobulinemia E and undue susceptibility to infection Pediatrics 1972 49 59 70 5059313
  5. [5]Eigenmann PA Sicherer SH Borkowski TA Cohen BA Sampson HA Prevalence of IgE-mediated food allergy among children with atopic dermatitis Pediatrics 1998 101 E8 9481027
  6. [6]Boyce JA Assa’ad A Burks AW Jones SM Sampson HA Wood RA Guidelines for the diagnosis and management of food allergy in the United States: Summary of the NIAID-sponsored Expert Panel Report J Allergy Clin Immunol 2010 126 1105 1118 21134568 PMC4241958
  7. [7]Lieberman P Nicklas RA Oppenheimer J Kemp SF Lang DM Bernstein DI The diagnosis and management of anaphylaxis practice parameter: 2010 update J Allergy Clin Immunol 2010 126 477 480 e1–42 20692689
  8. [8]Olivera A Eisner C Kitamura Y Dillahunt S Allende L Tuymetova G Sphingosine kinase 1 and sphingosine-1-phosphate receptor 2 are vital to recovery from anaphylactic shock in mice J Clin Invest 2010 120 1429 1440 20407207 PMC2860904
  9. [9]Kuehn HS Radinger M Gilfillan AM Measuring mast cell mediator release Curr Protoc Immunol 2010 38 Chapter 7: Unit7 21053305 PMC2982193
  10. [10]Cruse G Beaven MA Ashmole I Bradding P Gilfillan AM Metcalfe DD A truncated splice-variant of the FcepsilonRIbeta receptor subunit is critical for microtu-bule formation and degranulation in mast cells Immunity 2013 38 906 917 23643722 PMC3694348
  11. [11]Buckley RH The hyper-IgE syndrome Clin Rev Allergy Immunol 2001 20 139 154 11269224
  12. [12]Avery DT Deenick EK Ma CS Suryani S Simpson N Chew GY B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans J Exp Med 2010 207 155 171 20048285 PMC2812540
  13. [13]Speckmann C Enders A Woellner C Thiel D Rensing-Ehl A Schlesier M Reduced memory B cells in patients with hyper IgE syndrome Clin Immunol 2008 129 448 454 18835223
  14. [14]Yu D Rao S Tsai LM Lee SK He Y Sutcliffe EL The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment Immunity 2009 31 457 468 19631565
  15. [15]Nurieva RI Chung Y Martinez GJ Yang XO Tanaka S Matskevitch TD Bcl6 mediates the development of T follicular helper cells Science 2009 325 1001 1005 19628815 PMC2857334
  16. [16]Johnston RJ Poholek AC DiToro D Yusuf I Eto D Barnett B Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation Science 2009 325 1006 1010 19608860 PMC2766560
  17. [17]Xiong H Dolpady J Wabl M Curotto de Lafaille MA Lafaille JJ Sequential class switching is required for the generation of high affinity IgE antibodies J Exp Med 2012 209 353 364 22249450 PMC3280879
  18. [18]Erazo A Kutchukhidze N Leung M Christ AP Urban JF Jr Curotto de Lafaille MA Unique maturation program of the IgE response in vivo Immunity 2007 26 191 203 17292640 PMC1892589
  19. [19]Nurieva RI Chung Y Hwang D Yang XO Kang HS Ma L Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages Immunity 2008 29 138 149 18599325 PMC2556461
  20. [20]Ma CS Avery DT Chan A Batten M Bustamante J Boisson-Dupuis S Functional STAT3 deficiency compromises the generation of human T follicular helper cells Blood 2012 119 3997 4008 22403255 PMC3355712
  21. [21]Avery DT Ma CS Bryant VL Santner-Nanan B Nanan R Wong M STAT3 is required for IL-21-induced secretion of IgE from human naive B cells Blood 2008 112 1784 1793 18579794
  22. [22]Sampson HA Ho DG Relationship between food-specific IgE concentrations and the risk of positive food challenges in children and adolescents J Allergy Clin Immunol 1997 100 444 451 9338535
  23. [23]Klinker JF Seifert R Morphine and muscle relaxants are receptor-independent G-protein activators and cromolyn is an inhibitor of stimulated G-protein activity Inflamm Res 1997 46 46 50 9085143
  24. [24]Cohen RW Rosenstreich DL Discrimination between urticaria-prone and other allergic patients by intradermal skin testing with codeine J Allergy Clin Immunol 1986 77 802 807 3711548
  25. [25]Tsujimura Y Obata K Mukai K Shindou H Yoshida M Nishikado H Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis Immunity 2008 28 581 589 18342553
  26. [26]Saini SS Klion AD Holland SM Hamilton RG Bochner BS Macglashan DW Jr The relationship between serum IgE and surface levels of FcepsilonR on human leukocytes in various diseases: correlation of expression with FcepsilonRI on basophils but not on monocytes or eosinophils J Allergy Clin Immunol 2000 106 514 520 10984372
  27. [27]Traum D Timothee P Silver J Rose-John S Ernst M LaRosa DF IL-10-induced gp130 expression in mouse mast cells permits IL-6 trans-signaling J Leukoc Biol 2011 91 427 435 22140267 PMC3289398
  28. [28]Sonnenblick A Levy C Razin E Immunological trigger of mast cells by mono-meric IgE: effect on microphthalmia transcription factor, STAT3 network of interactions J Immunol 2005 175 1450 1455 16034081
  29. [29]Suzuki Y Yoshimaru T Inoue T Ra C Mitochondrial Ca2+ flux is a critical determinant of the Ca2+ dependence of mast cell degranulation J Leukoc Biol 2006 79 508 518 16365155
  30. [30]Kinoshita T Sawai N Hidaka E Yamashita T Koike K Interleukin-6 directly modulates stem cell factor-dependent development of human mast cells derived from CD34(+) cord blood cells Blood 1999 94 496 508 10397717
  31. [31]Drube S Heink S Walter S Lohn T Grusser M Gerbaulet A The receptor tyrosine kinase c-Kit controls IL-33 receptor signaling in mast cells Blood 2010 115 3899 3906 20200353
  32. [32]Zhou Z Gushiken FC Bolgiano D Salsbery BJ Aghakasiri N Jing N Signal transducer and activator of transcription 3 (STAT3) regulates collagen-induced platelet aggregation independently of its transcription factor activity Circulation 2013 127 476 485 23266857 PMC4472638

Cited by

Sorted by citations

Authors
Siegel, A. M., Stone, K. D., Cruse, G., Lawrence, M. G., Olivera, A., Jung, M.-Y., Barber, J. S., Freeman, A. F., Holland, S. M., O'Brien, M., Jones, N., Wisch, L. B., Kong, H. H., Desai, A., Farber, O., Gilfillan, A. M., Rivera, J., & Milner, J. D.
Affiliations
  • National Institute of Allergy and Infectious Diseases (US)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (US)
  • National Institutes of Health (US)
Corresponding author
Milner, Joshua D.
Venue
Journal of Allergy and Clinical Immunology
Publisher
Elsevier BV
Published
2013-12
Volume
132
Issue
6
Pages
1388-1396.e3
ISSN
0091-6749 (ISSN-L)
OpenAlex
W2158823847
Cited by
131
References
0
Citations by year
2026: 6 · 2025: 10 · 2024: 9 · 2023: 4 · 2022: 10 · 2021: 7 · 2020: 13 · 2019: 8 · 2018: 21 · 2017: 10 · 2016: 12 · 2015: 9 · 2014: 11
FWCI
5.90
Type
journal article
Language
en
Open access
Locations
  • Journal of Allergy and Clinical Immunology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Laboratoire d'Excellence Inflamex
  • Institut National de la Santé et de la Recherche Médicale
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases (ZIAAI001183, T32AI007610)
  • NIH Clinical Center
  • NHLBI Division of Intramural Research
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
  • Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
  • Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
Keywords
STAT3 mutations, autosomal dominant hyper-IgE syndrome, mast cell degranulation, food allergy, anaphylaxis, atopic dermatitis, IgE, basophil activation, FcεRI signaling, transgenic mouse model
MeSH terms
Adolescent, Adult, Aged, Animals, Cells, Cultured, Child, Child, Preschool, Dermatitis, Atopic, Female, Food Hypersensitivity, Humans, Immunoglobulin E, Infant, Job Syndrome, Male, Mast Cells, Mice, Inbred C57BL, Mice, Transgenic, Middle Aged, Mutation, Signal Transduction, Cell Degranulation, Incidence, Transgenes, STAT3 Transcription Factor, Mice, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review